EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Myeloid deficiency of Z‐DNA binding protein 1 restricts septic cardiomyopathy via promoting macrophage polarisation towards the M2‐subtype

Yifan Shi, Lu He, Jie Ni iD, Yuyuan Zhou, Xiaohua Yu, Yao Du, Yang Li, Xi Tan, Yufang Li, Xiaoying Xu, Si Sun, Lina Kang und 3 weitere

Clinical and Translational Medicine · 2025-05 · 15 (5)

DOI: 10.1002/ctm2.70315 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 27.04.2025. Verfasst von Yifan Shi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Cardiomyopathies, Sepsis, Macrophages, DNA-Binding Proteins. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Septic cardiomyopathy is a frequent complication in patients with sepsis and is associated with a high mortality rate. Given its clinical significance, understanding the precise underlying mechanism is of great value. Methods and results Our results unveiled that Z‐DNA binding protein 1 (ZBP1) is upregulated in myocardial tissues of lipopolysaccharide (LPS)‐treated mice. Single‐cell mRNA sequencing (scRNA‐seq) and single‐nucleus mRNA sequencing (snRNA‐seq) indicated that Zbp1 mRNA in endothelial cells, fibroblasts and macrophages appeared to be elevated by LPS, which is partially consistent with the results of immunofluorescence. Through echocardiography, we identified that global deletion of ZBP1 improves cardiac dysfunction and the survival rate of LPS‐treated mice. Mechanistically, snRNA‐seq showed that ZBP1 is mainly expressed in macrophages and deletion of ZBP1 promotes the macrophage polarisation towards M2‐subtype, which reduces inflammatory cell infiltration. Notably, myeloid‐specific deficiency of ZBP1 also promotes M2 macrophage polarisation and improves cardiac dysfunction, validating the role of macrophage‐derived ZBP1 in septic myocardial dysfunction. Finally, we revealed that LPS increases the transcription and expression of ZBP1 through signal transducer and activator of transcription 1 (STAT1). Fludarabine, the inhibitor of STAT1, could also promote M2 macrophage polarisation and improve cardiac dysfunction of LPS‐treated mice.

Conclusions

Our study provides evidence of a novel STAT1‐ZBP1 axis in macrophage promoting septic cardiomyopathy, and underscores the potential of macrophage‐derived ZBP1 as a therapeutic target for septic cardiomyopathy. Key points Macrophage‐derived ZBP1 exacerbates LPS‐induced myocardial dysfunction and inflammatory cell infiltration. Deletion of ZBP1 promotes macrophage polarisation from M1 to M2. STAT1‐ZBP1 axis promotes septic cardiomyopathy. ZBP1 has emerged as a potential therapeutic target for inflammation and septic cardiomyopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomyopathiesSepsisMacrophagesDNA-Binding ProteinsRNA-Binding ProteinsAnimalsMiceLipopolysaccharidesDisease Models, AnimalMice, Inbred C57BLMale

Stichwörter der Autor:innen

STAT1ZBP1macrophage polarisationmyocardial dysfunctionsepsis

Substanzen

DNA-Binding ProteinsZbp1 protein, mouseLipopolysaccharidesRNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Cardiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
  • Department of Neurosurgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
  • Department of Cardiology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  • Department of Cardiology, the Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, China.
  • Nanjing Key Laboratory for Cardiovascular Information and Health Engineering Medicine, Institute of Clinical Medicine, Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing, Jiangsu, China.

ORCID-Profile: Jie Ni, Jibo Han, Lintao Wang

Förderung

  • Natural Science Foundation of Zhejiang Province
  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • Medical Science and technology development Foundation,Nanjing Department of Health
  • Science and Technology Bureau of Jiaxing City
  • Zhejiang Provincial Health Bureau Science Foundation
  • National Key Research and Development Program of China

Zitieren

APA

Shi, Y., He, L., Ni, J., Zhou, Y., Yu, X., Du, Y., Li, Y., Tan, X., Li, Y., Xu, X., Sun, S., Kang, L., Xu, B., Han, J., & Wang, L. (2025). Myeloid deficiency of Z‐DNA binding protein 1 restricts septic cardiomyopathy via promoting macrophage polarisation towards the M2‐subtype. Clinical and Translational Medicine, 15(5). https://doi.org/10.1002/ctm2.70315

Vancouver

Shi Y, He L, Ni J, Zhou Y, Yu X, Du Y, et al. Myeloid deficiency of Z‐DNA binding protein 1 restricts septic cardiomyopathy via promoting macrophage polarisation towards the M2‐subtype. Clinical and Translational Medicine. 2025;15(5). doi:10.1002/ctm2.70315

BibTeX
@article{Shi2025,
  author = {Shi, Yifan and He, Lu and Ni, Jie and Zhou, Yuyuan and Yu, Xiaohua and Du, Yao and Li, Yang and Tan, Xi and Li, Yufang and Xu, Xiaoying and Sun, Si and Kang, Lina and Xu, Biao and Han, Jibo and Wang, Lintao},
  title = {Myeloid deficiency of Z‐DNA binding protein 1 restricts septic cardiomyopathy via promoting macrophage polarisation towards the M2‐subtype},
  journal = {Clinical and Translational Medicine},
  year = {2025},
  volume = {15},
  number = {5},
  doi = {10.1002/ctm2.70315}
}
Kostenlos starten →